These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene. Sherman L; Jacoby LB; Lampe J; Pelton P; Aguzzi A; Herrlich P; Ponta H Cancer Res; 1997 Nov; 57(21):4889-97. PubMed ID: 9354454 [TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis and central nervous system tumors in childhood. Mapstone TB Neurosurg Clin N Am; 1992 Oct; 3(4):771-9. PubMed ID: 1392574 [TBL] [Abstract][Full Text] [Related]
18. Prevention and control of neurofibromatosis: memorandum from a joint WHO/NNFF meeting. Bull World Health Organ; 1992; 70(2):173-82. PubMed ID: 1600579 [TBL] [Abstract][Full Text] [Related]
19. [Diagnostics of neurofibromatosis (Recklinghausen disease)]. Ardashev VN; Seriakov AP; Nikolaeva SN; Konev AV; Smolin AV Voen Med Zh; 2004 Jun; 325(6):41-4. PubMed ID: 15327140 [No Abstract] [Full Text] [Related]
20. Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes? Kehrer-Sawatzki H; Cooper DN J Med Genet; 2008 Oct; 45(10):622-31. PubMed ID: 18511569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]